NASDAQ: SEER
Seer, Inc.
Healthcare · Biotechnology
After hours: $1.75(+0.57%) · as of 4:10 PM ET
Market Cap
$95.67M
52w High
$2.41
52w Low
$1.65
P/E
-1.38
Volume
83.14K
Outstanding Shares
54.98M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 12.12% over the last year. Revenue declined 0.86% over the trailing twelve months. Operating margin moved from -630.87% to -496.38%. Free cash flow grew 1.34% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -496.38%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
2
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 5, 2026
Q3 FY26 · EPS est -$0.22 · Revenue est $3.54M
View